• This record comes from PubMed

Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects

. 2022 Jan 27 ; 41 (1) : 40. [epub] 20220127

Status PubMed-not-MEDLINE Language English Country England, Great Britain Media electronic

Document type Published Erratum

Links

PubMed 35086550
PubMed Central PMC8793270
DOI 10.1186/s13046-022-02247-y
PII: 10.1186/s13046-022-02247-y
Knihovny.cz E-resources

Erratum For

PubMed

See more in PubMed

Romito I, Porru M, Braghini MR, et al. Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects. J Exp Clin Cancer Res. 2021;40:364. doi: 10.1186/s13046-021-02154-8. PubMed DOI PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...